Neurocrine Biosciences to Present New Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia Patients, at the 2018 American Psychiatric Association Annual Meeting PR NewswireSAN DIEGO, May 2, 2018 /PRNewswire/ -- Neurocrine Biosciences Inc.
